346 related articles for article (PubMed ID: 18158592)
1. Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina.
Yokota T; Utsunomiya K; Taniguchi K; Gojo A; Kurata H; Tajima N
Jpn J Ophthalmol; 2007; 51(6):424-30. PubMed ID: 18158592
[TBL] [Abstract][Full Text] [Related]
2. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes.
Yokota T; Ma RC; Park JY; Isshiki K; Sotiropoulos KB; Rauniyar RK; Bornfeldt KE; King GL
Diabetes; 2003 Mar; 52(3):838-45. PubMed ID: 12606528
[TBL] [Abstract][Full Text] [Related]
3. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
[TBL] [Abstract][Full Text] [Related]
4. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
Mohammad G; AlSharif HM; Siddiquei MM; Ahmad A; Alam K; Abu El-Asrar AM
Ann Clin Lab Sci; 2018 Mar; 48(2):137-145. PubMed ID: 29678838
[TBL] [Abstract][Full Text] [Related]
5. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Hofni A; Shehata Messiha BA; Mangoura SA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
[TBL] [Abstract][Full Text] [Related]
6. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
7. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
8. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
9. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
11. Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.
Xu X; Zhu Q; Xia X; Zhang S; Gu Q; Luo D
Curr Eye Res; 2004 Apr; 28(4):251-6. PubMed ID: 15259294
[TBL] [Abstract][Full Text] [Related]
12. The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-β(2) , elucidated by treatment with CTGFsiRNA.
Yang H; Huang Y; Chen X; Liu J; Lu Y; Bu L; Xia L; Xiao W; Chen M; Nie Q; Liu Z
Acta Ophthalmol; 2010 Sep; 88(6):652-9. PubMed ID: 20039857
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells.
Kamiyama M; Utsunomiya K; Taniguchi K; Yokota T; Kurata H; Tajima N; Kondo K
J Atheroscler Thromb; 2003; 10(2):117-23. PubMed ID: 12740486
[TBL] [Abstract][Full Text] [Related]
14. Sources of PDGF expression in murine retina and the effect of short-term diabetes.
Cox OT; Simpson DA; Stitt AW; Gardiner TA
Mol Vis; 2003 Dec; 9():665-72. PubMed ID: 14685146
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic innervation regulates basement membrane thickening and pericyte number in rat retina.
Wiley LA; Rupp GR; Steinle JJ
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):744-8. PubMed ID: 15671308
[TBL] [Abstract][Full Text] [Related]
16. Blocking VEGF/Caveolin-1 signaling contributes to renal protection of fasudil in streptozotocin-induced diabetic rats.
Jin J; Peng C; Wu SZ; Chen HM; Zhang BF
Acta Pharmacol Sin; 2015 Jul; 36(7):831-40. PubMed ID: 25937636
[TBL] [Abstract][Full Text] [Related]
17. ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina.
Ye X; Xu G; Chang Q; Fan J; Sun Z; Qin Y; Jiang AC
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5226-33. PubMed ID: 20445124
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T
Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
